Wells Fargo analyst Peter Costa said he believes the Pennsylvania Commonwealth Court ruled on the side of UnitedHealth (UNH) that the state Department of Human Services violated the state's procurement code when it had previously awarded a Medicaid contract to Centene (CNC). Given this ruling, Costa thinks the state will have to start the procurement process for the third time. He views the court ruling as a modest positive for UnitedHealth and Aetna (AET) and a modest negative for Centene (CNC), though he also noted that this win was not in Centene's 2018 guidance. Costa has Outperform ratings on all three stocks mentioned.

Reports Q1 revenue $40.41B, consensus $36.54B. "Centene's first quarter results demonstrate the strength of our diversified platform. We are pleased to raise full year 2024 guidance as we look to maximize the positive momentum being generated by our core businesses. We are executing against our strategic plans for growth and increasing access to affordable, high-quality healthcare for our members and the communities we serve," said Chief Executive Officer of Centene, Sarah M. London.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Biohaven Pharmaceutical... To see the rest of the story go to thefly.com. See Story Here

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here